February 2012 Drug Update Information - Pharmacy Benefits ...

CODE
Lot #: 0000000, Exp 00/00/0000
RECALLING FIRM/MANUFACTURERR
Recalling
Firm: McKesson Packaging Services, Concord, NC, by letter on /about January 10,
2012.
Manufacturer: Omnicare Inc., Covington, KY. Firm initiated recall is ongoing.
REASON
Unit Dose Mispackaging; cartons labeled as Amlodipinee Tablets, NDC 76237-109-30 actually
contain blister
PRODUCT (CLASSS II)
Alprazolam Tablets, USP, 2 mg, Rx only, a) NDC 0603-2130-21 (100-count bottle), b) NDC
0603-2130-28 (500-count bottle) ). Recall # D-1185-2012
CODE
a) Lot #: T025D10A, exp. 06/12;
T026D10A, exp. 06/12; T023D10B, exp. 04/12; T024D10B,
exp. 04/12; T182H10A, exp. 09/ 12; T185H10A, exp. 10/ /12; T020J10A, exp. 10/ /12; T021J10A,
exp. 10/12; T003L10A, exp. 12/12; T178M10A, exp. 01/13; T179M10A, exp. 01/13;
T202B11A, exp. 02/ 13; T239C11A, exp. 02/ /13; T025D11A, exp. 03/13; T024D11A, exp. 03/13;
T026D11A, exp. 04/ 13; T027D11A, exp. 04/ /13; T019E11A, exp. 04/13; T020E11A, exp. 04/13;
T021E11A, exp. 04/13; T021H11A, exp. 07/ /13; T017J11A, exp. 08/ /13; T016J11A, exp. 08/ /13;
T020K11A, exp. 09/ 13; b) Lot #: T148M09A, exp. 12/11; T164M09A, exp. 12/11; T022D10A,
exp. 04/12; T023D10A, exp. 04/ 12; T024D10A, exp. 04/ /12; T026D108B, exp. 06/12;
T183H10B, exp. 10/ 12; T184H10A, exp. 10/ /12; T186H10A, exp. 10/12; T187H10A, exp. 10/12;
T180M10A, exp. 01/ /13; T076B11A, exp. 02/13; T201B11A, exp. 02/13; T240C11A, exp. 02/13;
T028D11A, exp. 04/ 13; T029D11A, exp. 03/ /13; T017E11A, exp. 05/13; T018E11A, exp. 03/13;
T022H11A, exp. 07/ 13; T018J11A, exp. 08/ 13; T019K11A, exp. 09/ /13
RECALLING FIRM/MANUFACTURERR
Vintage Pharmaceuti
icals LLC dba Qualitest Pharmaceuticals, Huntsville, AL, by
letters on
December 30, 2011.
REASON
Tablet Separation: Premature tablet breakage.
PRODUCT (CLASSS II)
CARDURA XL (doxazosin mesylate extended release tablets) 4 mg, , 30 ct bottle, NDC 0049-
2710-30,
Recall # D-1186-2012
CODE
Lot V101161, Exp. 04/12
RECALLING FIRM/MANUFACTURER
Pfizer US
Pharmaceutical Group, New York, NY, by letter on January 11, 2012.
Firm initiated
recall is ongoing.
REASON
Failed USP Dissolution Test Requirements: Stability testing yielded an out of specification result
for an individual value at 8 hour dissolution.
PRODUCT (CLASSS II)
Acetaminophen and Codeine Phosphate CIIII Tablets USP 300 mg/60
mg, (Each tablet contains:
Acetaminophen USP...300 mg and Codeine Phosphate USP...60 mg) ), 100 count bottles, Rx
Only, NDC 0406-0485-01. Recall # D-1183-2012
CODE
Lot number: 0485T81671, Expiration date: 10/2013
20